Gene therapy of malignant gliomas: a phase I study of IL-4-HSV-TK gene-modified autologous tumor to elicit an immune response.
Okada
H
H
University of Pittsburgh Cancer Institute, Pennsylvania, USA.
Pollack
I F
IF
Lotze
M T
MT
Lunsford
L D
LD
Kondziolka
D
D
Lieberman
F
F
Schiff
D
D
Attanucci
J
J
Edington
H
H
Chambers
W
W
Robbins
P
P
Baar
J
J
Kinzler
D
D
Whiteside
T
T
Elder
E
E
D001932:Brain Neoplasms / Q000235:genetics* / Q000276:immunology; D002985:Clinical Protocols; D015316:Genetic Therapy; D005910:Glioma / Q000276:immunology / Q000628:therapy*; D006801:Humans; D015847:Interleukin-4 / Q000235:genetics*; D018139:Simplexvirus / Q000201:enzymology / Q000235:genetics*; D013937:Thymidine Kinase / Q000235:genetics*; D014161:Transduction, Genetic
D015847:Interleukin-4; D013937:Thymidine Kinase